• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

儿童心力衰竭药物滴定的挑战。

Challenges in medication titration in children with heart failure.

作者信息

Yester Jessie, Nandi Deipanjan

机构信息

The Heart Center, Department of Pediatrics, Nationwide Children's Hospital, The Ohio State University, Columbus, Ohio.

出版信息

JHLT Open. 2025 Aug 5;10:100358. doi: 10.1016/j.jhlto.2025.100358. eCollection 2025 Nov.

DOI:10.1016/j.jhlto.2025.100358
PMID:40893632
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12391281/
Abstract

The management of pediatric heart failure and titration of oral medical therapies remains in its infancy. Burdened by a lack of understanding of the diverse pediatric heart failure etiologies, limitations in clinical trials, a lack of society guidelines, as well as other health care systemic issues, titration of medications is greatly lacking. We herein review the difficulties with medication titration in pediatric heart failure, and highlight important next steps to remedy the situation.

摘要

小儿心力衰竭的管理及口服药物治疗的滴定仍处于起步阶段。由于对小儿心力衰竭病因的多样性缺乏了解、临床试验存在局限性、缺乏社会指南以及其他医疗系统问题,药物滴定严重不足。我们在此回顾小儿心力衰竭药物滴定的困难,并强调改善这种情况的重要后续步骤。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/99a6/12391281/a9078e77120b/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/99a6/12391281/a9078e77120b/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/99a6/12391281/a9078e77120b/gr1.jpg

相似文献

1
Challenges in medication titration in children with heart failure.儿童心力衰竭药物滴定的挑战。
JHLT Open. 2025 Aug 5;10:100358. doi: 10.1016/j.jhlto.2025.100358. eCollection 2025 Nov.
2
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
3
Nurse-led titration of angiotensin converting enzyme inhibitors, beta-adrenergic blocking agents, and angiotensin receptor blockers for people with heart failure with reduced ejection fraction.由护士主导对射血分数降低的心力衰竭患者进行血管紧张素转换酶抑制剂、β肾上腺素能阻滞剂和血管紧张素受体阻滞剂的滴定。
Cochrane Database Syst Rev. 2015 Dec 21;2015(12):CD009889. doi: 10.1002/14651858.CD009889.pub2.
4
Systemic Inflammatory Response Syndrome全身炎症反应综合征
5
Pharmacological treatment of children with gastro-oesophageal reflux.胃食管反流患儿的药物治疗
Cochrane Database Syst Rev. 2014 Nov 24;2014(11):CD008550. doi: 10.1002/14651858.CD008550.pub2.
6
Treatment of central sleep apnea in adults: an American Academy of Sleep Medicine clinical practice guideline.成人中枢性睡眠呼吸暂停的治疗:美国睡眠医学会临床实践指南
J Clin Sleep Med. 2025 Aug 18. doi: 10.5664/jcsm.11858.
7
Acupuncture for depression.针灸治疗抑郁症。
Cochrane Database Syst Rev. 2018 Mar 4;3(3):CD004046. doi: 10.1002/14651858.CD004046.pub4.
8
Atypical antipsychotics for disruptive behaviour disorders in children and youths.用于治疗儿童和青少年破坏性行为障碍的非典型抗精神病药物。
Cochrane Database Syst Rev. 2017 Aug 9;8(8):CD008559. doi: 10.1002/14651858.CD008559.pub3.
9
Dietary Approaches to Stop Hypertension (DASH) for the primary and secondary prevention of cardiovascular diseases.用于心血管疾病一级和二级预防的饮食预防高血压(DASH)方案。
Cochrane Database Syst Rev. 2025 May 6;5(5):CD013729. doi: 10.1002/14651858.CD013729.pub2.
10
Single-Center Experience with Sacubitril/Valsartan in Patients with Congenital Heart Disease.沙库巴曲缬沙坦治疗先天性心脏病患者的单中心经验
Pediatr Cardiol. 2025 Jul 4. doi: 10.1007/s00246-025-03938-x.

本文引用的文献

1
Pediatric Chronic Heart Failure: Age-Specific Considerations of Medical Therapy.儿科慢性心力衰竭:医学治疗的年龄特异性考虑。
Physiol Res. 2024 Nov 29;73(S2):S597-S613. doi: 10.33549/physiolres.935438.
2
Suboptimal Titration of Heart Failure Medications in Pediatric Patients: Baseline Data from ACTION.儿科患者心力衰竭药物滴定未达最佳状态:ACTION研究的基线数据
J Card Fail. 2025 Apr;31(4):741-745. doi: 10.1016/j.cardfail.2024.10.445. Epub 2024 Nov 20.
3
Sacubitril/Valsartan in Pediatric Heart Failure (PANORAMA-HF): A Randomized, Multicenter, Double-Blind Trial.
沙库巴曲缬沙坦治疗儿科心力衰竭(PANORAMA-HF):一项随机、多中心、双盲试验。
Circulation. 2024 Nov 26;150(22):1756-1766. doi: 10.1161/CIRCULATIONAHA.123.066605. Epub 2024 Sep 25.
4
Burden of Pediatric Heart Failure in the United States.美国小儿心力衰竭负担
J Am Coll Cardiol. 2022 May 17;79(19):1917-1928. doi: 10.1016/j.jacc.2022.03.336.
5
Extended recovery of cardiac function after severe infantile cardiomyopathy presentation of Barth syndrome.患有巴斯综合征的严重婴儿型心肌病出现后心脏功能的长期恢复
JIMD Rep. 2021 Dec 28;63(2):114-122. doi: 10.1002/jmd2.12264. eCollection 2022 Mar.
6
Challenges in clinical trials for children and young people.儿童和青少年临床试验面临的挑战。
Arch Dis Child. 2021 Apr;106(4):321-325. doi: 10.1136/archdischild-2019-318676. Epub 2020 Oct 19.
7
Establishing Baseline Metrics of Heart Failure Medication Use in Children: A Collaborative Effort from the ACTION Network.建立儿童心力衰竭药物使用的基线指标:来自 ACTION 网络的合作努力。
Pediatr Cardiol. 2021 Feb;42(2):315-323. doi: 10.1007/s00246-020-02485-x. Epub 2020 Oct 12.
8
Pediatric Heart Failure: An Evolving Public Health Concern.小儿心力衰竭:一个不断演变的公共卫生问题。
J Pediatr. 2020 Mar;218:217-221. doi: 10.1016/j.jpeds.2019.09.049. Epub 2019 Nov 15.
9
Association of Changes in Heart Failure Treatment With Patients' Health Status: Real-World Evidence From CHAMP-HF.心力衰竭治疗变化与患者健康状况的关联:来自 CHAMP-HF 的真实世界证据。
JACC Heart Fail. 2019 Jul;7(7):615-625. doi: 10.1016/j.jchf.2019.03.020. Epub 2019 Jun 5.
10
Medical Therapy for Heart Failure With Reduced Ejection Fraction: The CHAMP-HF Registry.射血分数降低的心力衰竭的药物治疗:CHAMP-HF 注册研究。
J Am Coll Cardiol. 2018 Jul 24;72(4):351-366. doi: 10.1016/j.jacc.2018.04.070.